David Afshar Biography and Net Worth

CFO of Aveanna Healthcare

Dave Afshar brings more than 20 years of public accounting, regulatory, and healthcare industry experience to Aveanna. Mr. Afshar joined the Aveanna management team in February 2018 and is responsible for finance, accounting, tax, treasury, and billing office operations.

Prior to Aveanna, Mr. Afshar served for eight years as Chief Financial Officer of ApolloMD, a large multispecialty physician practice. He has also served as an Inspections Leader with the Public Company Accounting Oversight Board, where he led inspections of “Big Four” audit firms. In addition, he has served as Chief Accounting Officer and Interim CFO with Regency Hospital Company, a long-term acute care provider.

Mr. Afshar received his undergraduate degree in Accounting from the University of Maryland and started his career with Ernst & Young, where he spent the majority of his time in the Health Sciences practice and served as Senior Manager.

What is David Afshar's net worth?: The estimated net worth of David Afshar is at least $1.61 million as of August 24th, 2022. Mr. Afshar owns 288,240 shares of Aveanna Healthcare stock worth more than $1,605,497 as of November 17th. This net worth estimate does not reflect any other assets that Mr. Afshar may own. Learn More about David Afshar's net worth.
How do I contact David Afshar?: The corporate mailing address for Mr. Afshar and other Aveanna Healthcare executives is 400 INTERSTATE NORTH PARKWAY STE 1700, ATLANTA GA, 30339. Aveanna Healthcare can also be reached via phone at 770-441-1580 and via email at [email protected]. Learn More on David Afshar's contact information.
Has David Afshar been buying or selling shares of Aveanna Healthcare?: David Afshar has not been actively trading shares of Aveanna Healthcare during the past quarter. Most recently, on Wednesday, August 24th, David Afshar bought 10,000 shares of Aveanna Healthcare stock. The stock was acquired at an average cost of $2.01 per share, with a total value of $20,100.00. Following the completion of the transaction, the chief financial officer now directly owns 288,240 shares of the company's stock, valued at $579,362.40. Learn More on David Afshar's trading history.
Who are Aveanna Healthcare's active insiders?: Aveanna Healthcare's insider roster includes David Afshar (CFO), Jeff Shaner (COO), and Tony Strange (Insider). Learn More on Aveanna Healthcare's active insiders.

David Afshar Insider Trading History at Aveanna Healthcare

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/24/2022	Buy	10,000	$2.01	$20,100.00	288,240
5/16/2022	Buy	12,036	$2.86	$34,422.96	272,380
12/1/2021	Buy	4,760	$6.26	$29,797.60
11/17/2021	Buy	3,850	$7.73	$29,760.50
8/13/2021	Buy	5,070	$9.97	$50,547.90	19,604
4/30/2021	Buy	4,284	$11.67	$49,994.28	14,534

David Afshar Buying and Selling Activity at Aveanna Healthcare

Aveanna Healthcare Company Overview

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Today's Range

Now: $5.57

$5.38

$5.68

50 Day Range

MA: $5.15

$4.22

$5.95

2 Week Range

Now: $5.57

$1.83

$6.19

Volume

269,209 shs

Average Volume

281,377 shs

Market Capitalization

$1.08 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.13

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.